Theravance, Inc

Theravance, inc email format

Verified email-pattern data for Theravance, Inc is currently limited. You can still use the company insights and contact sections below.
Theravance, Inc is now called Innoviva. Innoviva is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva's website at www.inva.com.

Company Details

Employees
6
Address
951 Gateway Blvd, South San Francisco,ca 94080,united States
Industry
Investment Management
HQ
South San Francisco, CA
Looking for a particular Theravance, Inc employee's phone or email?

Theravance, Inc Questions

Explore related pages

Related company profiles:

Top Theravance, Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant